Simon M. Everett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simon M. Everett has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Wafaa Ahmed
Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
7 shared publications - Wei On
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
7 shared publications - Colin John Rees
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
5 shared publications Matthew T Huggett
Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK
5 shared publications- Barbara Braden
Medical Department B, University Hospital Münster, 48149 Munster, Germany
4 shared publications Bettina Kluettgens
British Society of Gastroenterology, London, London, UK
4 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e168-e175
Best practice in delivering live endoscopy events in 2026 and beyond
Live endoscopy events (LEEs) have become a valuable educational tool in gastroenterology, providing a real-time demonstration of advanced endoscopic techniques. This article reflects on the BSG EndoBridge meeting held in January 2026, which successfully transmitted mixed endoscopy cases live from the UK and India. LEEs deliver unique educational benefits by showcasing expert decision-making, adaptive responses to unexpected challenges and interactive discussions in real-time. They facilitate knowledge sharing, networking and the exchange of practical tips across diverse audiences from trainees to specialist endoscopists. Live demonstrations capture the unscripted complexities of real-life clinical scenarios, including unpredictable patient anatomy and time-sensitive decision-making. Successful delivery requires careful attention to technology (Unified Communication platforms), robust infrastructure, thorough pre-event testing and strict adherence to patient safety guidelines. Key structural elements include a course director with overriding responsibility for safety, experienced moderators and panellists, and patient advocates. Clear communication protocols, minimal distractions in the procedure room and the ability to instantly cut the feed if needed are essential to maintain clinical standards. To ensure both patient safety and educational effectiveness, the course must adhere to rigorous ethical standards. Beyond compliance, these standards foster a culture of transparency by prioritising patient well-being and a robust informed consent process. The course creates a safe environment for delegates to critically analyse real-world complications and adverse events, which is essential for deep clinical learning. When properly structured, LEEs balance high-value interactive education with patient safety, remaining a powerful resource for endoscopy training in the digital era.
- 3 June 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e168-e175
Open AccessBest practice in delivering live endoscopy events in 2026 and beyond
Live endoscopy events (LEEs) have become a valuable educational tool in gastroenterology, providing a real-time demonstration of advanced endoscopic techniques. This article reflects on the BSG EndoBridge meeting held in January 2026, which successfully transmitted mixed endoscopy cases live from the UK and India. LEEs deliver unique educational benefits by showcasing expert decision-making, adaptive responses to unexpected challenges and interactive discussions in real-time. They facilitate knowledge sharing, networking and the exchange of practical tips across diverse audiences from trainees to specialist endoscopists. Live demonstrations capture the unscripted complexities of real-life clinical scenarios, including unpredictable patient anatomy and time-sensitive decision-making. Successful delivery requires careful attention to technology (Unified Communication platforms), robust infrastructure, thorough pre-event testing and strict adherence to patient safety guidelines. Key structural elements include a course director with overriding responsibility for safety, experienced moderators and panellists, and patient advocates. Clear communication protocols, minimal distractions in the procedure room and the ability to instantly cut the feed if needed are essential to maintain clinical standards. To ensure both patient safety and educational effectiveness, the course must adhere to rigorous ethical standards. Beyond compliance, these standards foster a culture of transparency by prioritising patient well-being and a robust informed consent process. The course creates a safe environment for delegates to critically analyse real-world complications and adverse events, which is essential for deep clinical learning. When properly structured, LEEs balance high-value interactive education with patient safety, remaining a powerful resource for endoscopy training in the digital era.
- Open Access
- 28 May 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e134-e144
Optimisation of ERCP for common bile duct stones
Common bile duct (CBD) stones are a frequent cause of biliary pathology, with clinical presentations ranging from incidental findings to life-threatening cholangitis and pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is currently considered the standard technique for removing CBD stones; however, it carries significant risks and is subject to considerable variation in practice. This review outlines strategies to optimise ERCP utilisation and outcomes through improved patient selection, procedural planning and postprocedure management. Preprocedural optimisation begins with careful risk stratification using established guidelines to minimise unnecessary ERCP. The use of adjunctive imaging modalities such as magnetic resonance cholangiopancreatography, endoscopic ultrasound (EUS) or, where available, same-session EUS-ERCP can significantly reduce negative procedures. Anticipation of procedural difficulty based on stone size, number and anatomical factors enables appropriate triage to specialist centres, improving first-session clearance rates. Advances in endoscopic techniques including endoscopic papillary large balloon dilatation, mechanical lithotripsy and cholangioscopy-guided lithotripsy have enhanced the management of large and complex stones. These techniques can lead to increased single-session success and reduce the need for repeat interventions. Optimising ERCP practice requires a patient-centred, guideline-driven approach supported by service-level improvements such as regional networks and multidisciplinary collaboration. By integrating careful triage with advanced endoscopic techniques, clinicians can reduce unnecessary procedures, minimise complications and achieve successful bile duct clearance.
- 28 May 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e134-e144
Open AccessOptimisation of ERCP for common bile duct stones
Common bile duct (CBD) stones are a frequent cause of biliary pathology, with clinical presentations ranging from incidental findings to life-threatening cholangitis and pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is currently considered the standard technique for removing CBD stones; however, it carries significant risks and is subject to considerable variation in practice. This review outlines strategies to optimise ERCP utilisation and outcomes through improved patient selection, procedural planning and postprocedure management. Preprocedural optimisation begins with careful risk stratification using established guidelines to minimise unnecessary ERCP. The use of adjunctive imaging modalities such as magnetic resonance cholangiopancreatography, endoscopic ultrasound (EUS) or, where available, same-session EUS-ERCP can significantly reduce negative procedures. Anticipation of procedural difficulty based on stone size, number and anatomical factors enables appropriate triage to specialist centres, improving first-session clearance rates. Advances in endoscopic techniques including endoscopic papillary large balloon dilatation, mechanical lithotripsy and cholangioscopy-guided lithotripsy have enhanced the management of large and complex stones. These techniques can lead to increased single-session success and reduce the need for repeat interventions. Optimising ERCP practice requires a patient-centred, guideline-driven approach supported by service-level improvements such as regional networks and multidisciplinary collaboration. By integrating careful triage with advanced endoscopic techniques, clinicians can reduce unnecessary procedures, minimise complications and achieve successful bile duct clearance.
- Open Access
- 8 April 2026
- Published by BMJ in Frontline Gastroenterology
Factors associated with adherence to standard guidelines for ERCP in the management of bile duct stones
Objective Clinical guidelines provide evidence-based recommendations on common bile duct (CBD) stone management, though there is little guidance on best practice for sphincterotomy or X-ray acquisitions. Little is known about adherence to these guidelines. Design/method A national survey was distributed to endoscopic retrograde cholangiopancreatography (ERCP) practitioners (British Society of Gastroenterology (BSG) Endoscopy Quality Improvement Programme). Responses to four clinical scenarios were graded as correct or incorrect in relation to guidelines. These related to the decision to proceed to ERCP based on initial imaging (question 1), management of large CBD stones (question 2), irretrievable stones (question 3) and prophylactic pancreatic duct stent placement (question 4). Adherence to guidelines was evaluated according to practitioner characteristics. Variation in sphincterotomy technique and intraprocedural imaging was analysed. Results Responses were received from 389 ERCP practitioners (74% response rate). Most were consultant physicians (84%), 37% aged ≥55 years and 4% female. Endoscopic ultrasound (EUS) was performed by 31%. Regular attendance at ≥2 ERCP-related continued professional development (CPD) activities/year was reported by 58%. Responses aligned with BSG/European Society of Gastrointestinal Endoscopy guidelines in 90.3% (q1), 72.1% (q2), 89.7% (q3) and 75.8% (q4). Greater adherence was noted in q2 with physician specialty (p=0.002); in q3 in physicians (p=0.026) that practise EUS (p=0.006); in q4 in physicians (pConclusion Despite broad alignment with core clinical guidelines, adherence is variable.
- 8 April 2026
- Published by BMJ in Frontline Gastroenterology
Open AccessFactors associated with adherence to standard guidelines for ERCP in the management of bile duct stones
Objective Clinical guidelines provide evidence-based recommendations on common bile duct (CBD) stone management, though there is little guidance on best practice for sphincterotomy or X-ray acquisitions. Little is known about adherence to these guidelines. Design/method A national survey was distributed to endoscopic retrograde cholangiopancreatography (ERCP) practitioners (British Society of Gastroenterology (BSG) Endoscopy Quality Improvement Programme). Responses to four clinical scenarios were graded as correct or incorrect in relation to guidelines. These related to the decision to proceed to ERCP based on initial imaging (question 1), management of large CBD stones (question 2), irretrievable stones (question 3) and prophylactic pancreatic duct stent placement (question 4). Adherence to guidelines was evaluated according to practitioner characteristics. Variation in sphincterotomy technique and intraprocedural imaging was analysed. Results Responses were received from 389 ERCP practitioners (74% response rate). Most were consultant physicians (84%), 37% aged ≥55 years and 4% female. Endoscopic ultrasound (EUS) was performed by 31%. Regular attendance at ≥2 ERCP-related continued professional development (CPD) activities/year was reported by 58%. Responses aligned with BSG/European Society of Gastrointestinal Endoscopy guidelines in 90.3% (q1), 72.1% (q2), 89.7% (q3) and 75.8% (q4). Greater adherence was noted in q2 with physician specialty (p=0.002); in q3 in physicians (p=0.026) that practise EUS (p=0.006); in q4 in physicians (pConclusion Despite broad alignment with core clinical guidelines, adherence is variable.
- Open Access
- 10 March 2026
- Published by BMJ in Frontline Gastroenterology
British Society of Gastroenterology interim technical review and position on the use of lumen apposing metal stents during therapeutic endoscopic ultrasound following the urgent medical device recall of the AXIOS stent and electrocautery enhanced delivery system
Background On 20 December 2025, Boston Scientific initiated an urgent field safety notice and recall of selected Hot AXIOS lumen-apposing metal stent (LAMS) systems (6×8 mm, 8×8 mm and 20×10 mm) following reports of deployment and expansion failures at the time of delivery. These devices are widely used in the UK for therapeutic endoscopic ultrasound (T-EUS), including pancreatic fluid collection (PFC) drainage, EUS-guided gallbladder drainage (EUS-GBD), choledochoduodenostomy (EUS-CDD), gastrojejunostomy (EUS-GJ) and EUS-Directed transgastric endoscopic retrograde cholangio pancreatography (ERCP) (EDGE) procedures. The recall has immediate implications for urgent and complex interventions. Methods The British Society of Gastroenterology (BSG) Endoscopy Committee convened an expert working group comprising members of the committee and UK T-EUS leaders. Using evidence synthesised for the forthcoming BSG T-EUS Guidelines, the group developed consensus-based interim recommendations addressing alternative devices, technical strategies, salvage of stent maldeployment and governance measures. All recommendations achieved 100% agreement and were ratified by the BSG Endoscopy Committee. Results For PFC drainage and EUS-GBD, unaffected AXIOS sizes and alternative LAMS (eg, HOT SPAXUS, Z-EUS) remain viable options, with plastic stents or percutaneous approaches as adjuncts. The greatest impact is in malignant distal biliary obstruction, where withdrawal of 6×8 mm and 8×8 mm devices necessitates consideration of 10×10 mm LAMS in selected cases, alternative LAMS, tubular self-expanding metal stents, EUS-rendezvous, EUS-guided hepaticogastrostomy or antegrade stenting. For EUS-GJ and EDGE, the use of smaller LAMS or staged techniques is advised. Practical guidance for recognition and rescue of LAMS maldeployment is summarised, alongside recommendations for enhanced governance, regional collaboration and prospective data capture. Conclusion This interim BSG position statement provides pragmatic, consensus-driven guidance to maintain safe and effective T-EUS practice in the UK following the AXIOS recall. These recommendations support clinical decision-making during this period of device limitation and complement forthcoming national guidelines.
- 10 March 2026
- Published by BMJ in Frontline Gastroenterology
Open AccessBritish Society of Gastroenterology interim technical review and position on the use of lumen apposing metal stents during therapeutic endoscopic ultrasound following the urgent medical device recall of the AXIOS stent and electrocautery enhanced delivery system
Background On 20 December 2025, Boston Scientific initiated an urgent field safety notice and recall of selected Hot AXIOS lumen-apposing metal stent (LAMS) systems (6×8 mm, 8×8 mm and 20×10 mm) following reports of deployment and expansion failures at the time of delivery. These devices are widely used in the UK for therapeutic endoscopic ultrasound (T-EUS), including pancreatic fluid collection (PFC) drainage, EUS-guided gallbladder drainage (EUS-GBD), choledochoduodenostomy (EUS-CDD), gastrojejunostomy (EUS-GJ) and EUS-Directed transgastric endoscopic retrograde cholangio pancreatography (ERCP) (EDGE) procedures. The recall has immediate implications for urgent and complex interventions. Methods The British Society of Gastroenterology (BSG) Endoscopy Committee convened an expert working group comprising members of the committee and UK T-EUS leaders. Using evidence synthesised for the forthcoming BSG T-EUS Guidelines, the group developed consensus-based interim recommendations addressing alternative devices, technical strategies, salvage of stent maldeployment and governance measures. All recommendations achieved 100% agreement and were ratified by the BSG Endoscopy Committee. Results For PFC drainage and EUS-GBD, unaffected AXIOS sizes and alternative LAMS (eg, HOT SPAXUS, Z-EUS) remain viable options, with plastic stents or percutaneous approaches as adjuncts. The greatest impact is in malignant distal biliary obstruction, where withdrawal of 6×8 mm and 8×8 mm devices necessitates consideration of 10×10 mm LAMS in selected cases, alternative LAMS, tubular self-expanding metal stents, EUS-rendezvous, EUS-guided hepaticogastrostomy or antegrade stenting. For EUS-GJ and EDGE, the use of smaller LAMS or staged techniques is advised. Practical guidance for recognition and rescue of LAMS maldeployment is summarised, alongside recommendations for enhanced governance, regional collaboration and prospective data capture. Conclusion This interim BSG position statement provides pragmatic, consensus-driven guidance to maintain safe and effective T-EUS practice in the UK following the AXIOS recall. These recommendations support clinical decision-making during this period of device limitation and complement forthcoming national guidelines.
- 23 January 2026
- Published by BMJ in Frontline Gastroenterology
Implications of endoscopy complications and non-clinical management strategies
Endoscopy is integral to modern gastrointestinal care but carries inherent risks that extend beyond clinical outcomes. While procedural complications are well documented, their psychological, emotional and organisational repercussions are underexplored. This review highlights the implications of endoscopic complications on patients, families, clinicians and healthcare systems. It also aims to discuss the medicolegal aspects around the issue and propose strategies to handle the non-clinical aspects of endoscopic complication.
- 23 January 2026
- Published by BMJ in Frontline Gastroenterology
Implications of endoscopy complications and non-clinical management strategies
Endoscopy is integral to modern gastrointestinal care but carries inherent risks that extend beyond clinical outcomes. While procedural complications are well documented, their psychological, emotional and organisational repercussions are underexplored. This review highlights the implications of endoscopic complications on patients, families, clinicians and healthcare systems. It also aims to discuss the medicolegal aspects around the issue and propose strategies to handle the non-clinical aspects of endoscopic complication.
- Open Access
- 14 January 2026
- Published by BMJ in Frontline Gastroenterology
BSG, ACPGBI and AUGIS guidance on the scope of professional practice for clinical endoscopists
Background: This document focuses on the scope of professional practice for clinical endoscopists (previously known as non-medical endoscopists/nurse endoscopists). Clinical endoscopists not only contribute significantly to diagnostic gastrointestinal (GI) endoscopy services, performing upper GI endoscopy, flexible sigmoidoscopy and colonoscopy, but are extending their scope of practice to include more complex procedures such as bowel cancer screening colonoscopy and complex polypectomy. Aim: The previous British Society of Gastroenterology (BSG) Working Party Report on this issue was published in 2005. This revised document aims to provide updated guidance on professional aspects of the clinical endoscopist roles and responsibilities, ensuring safe, high-quality care for patients. Methods: The present document was produced by a guidance development group (GDG) including nurse consultants, clinical endoscopists and gastroenterologists, with experience in training and leading teams of clinical endoscopists. The first draft was developed by clinical endoscopists within the GDG, based on a comprehensive literature review. The wider GDG was then invited to review and contribute to the document and its recommendations. It was recognised that there was a paucity of high-quality evidence and the recommendations have been developed based on the best evidence available and consensus. Consensus was achieved through anonymised electronic voting among the GDG, with at least 80% agreement required for statements to be included. Results: 23 recommendations achieved consensus outlining the roles and responsibilities of clinical endoscopists and encompassing three key components regarding the scope of professional practice: medicolegal aspects of professional practice; training, education and continued professional development; and care of the patient pre, peri and post endoscopy. Conclusions: Clinical endoscopists make a vital contribution to endoscopy, gastroenterology and colorectal services. The present document offers guidance concerning best practice for clinical endoscopists, outlining a path from training to independent practice, management and expansion of practice. The implementation of these recommendations will lead to safer and more effective use of clinical endoscopists within our services, with continuous support and mentorship to promote the expansion of their practice, while ensuring the appropriate governance protocols are in place to provide patients with excellent care in endoscopy.
- 14 January 2026
- Published by BMJ in Frontline Gastroenterology
Open AccessBSG, ACPGBI and AUGIS guidance on the scope of professional practice for clinical endoscopists
Background: This document focuses on the scope of professional practice for clinical endoscopists (previously known as non-medical endoscopists/nurse endoscopists). Clinical endoscopists not only contribute significantly to diagnostic gastrointestinal (GI) endoscopy services, performing upper GI endoscopy, flexible sigmoidoscopy and colonoscopy, but are extending their scope of practice to include more complex procedures such as bowel cancer screening colonoscopy and complex polypectomy. Aim: The previous British Society of Gastroenterology (BSG) Working Party Report on this issue was published in 2005. This revised document aims to provide updated guidance on professional aspects of the clinical endoscopist roles and responsibilities, ensuring safe, high-quality care for patients. Methods: The present document was produced by a guidance development group (GDG) including nurse consultants, clinical endoscopists and gastroenterologists, with experience in training and leading teams of clinical endoscopists. The first draft was developed by clinical endoscopists within the GDG, based on a comprehensive literature review. The wider GDG was then invited to review and contribute to the document and its recommendations. It was recognised that there was a paucity of high-quality evidence and the recommendations have been developed based on the best evidence available and consensus. Consensus was achieved through anonymised electronic voting among the GDG, with at least 80% agreement required for statements to be included. Results: 23 recommendations achieved consensus outlining the roles and responsibilities of clinical endoscopists and encompassing three key components regarding the scope of professional practice: medicolegal aspects of professional practice; training, education and continued professional development; and care of the patient pre, peri and post endoscopy. Conclusions: Clinical endoscopists make a vital contribution to endoscopy, gastroenterology and colorectal services. The present document offers guidance concerning best practice for clinical endoscopists, outlining a path from training to independent practice, management and expansion of practice. The implementation of these recommendations will lead to safer and more effective use of clinical endoscopists within our services, with continuous support and mentorship to promote the expansion of their practice, while ensuring the appropriate governance protocols are in place to provide patients with excellent care in endoscopy.
- 27 November 2025
- Published by BMJ in Frontline Gastroenterology
Is it time for a paradigm change in the management of malignant distal biliary obstruction in the UK?
- 27 November 2025
- Published by BMJ in Frontline Gastroenterology
Is it time for a paradigm change in the management of malignant distal biliary obstruction in the UK?
- Open Access
- 14 October 2025
- Published by BMJ in Frontline Gastroenterology
British Society of Gastroenterology (BSG) and Association of Coloproctology of Great Britain and Ireland (ACPGBI) guidelines on the role of faecal immunochemical testing (FIT) in the endoscopic investigation of iron deficiency anaemia (IDA) 2025
The rapidly emerging evidence base for the use of faecal immunochemical testing (FIT) in the investigation of possible colorectal malignancy has resulted in widespread use of FIT as a triage tool between primary and secondary care. This has caused some disruption to established investigation pathways for iron deficiency anaemia (IDA) and confusion regarding the role of FIT in planning any investigation, especially with regard to the upper gastrointestinal (UGI) tract. To provide some clarity, the British Society of Gastroenterology (BSG) commissioned a small group drawn from the guideline groups for both the BSG faecal immunochemical test (FIT)1 and iron deficiency anaemia (IDA)2 guidelines, the BSG endoscopy section and the Association of Coloproctology of Great Britain and Ireland (ACPGBI) to assess current evidence and produce guidelines.
- 14 October 2025
- Published by BMJ in Frontline Gastroenterology
Open AccessBritish Society of Gastroenterology (BSG) and Association of Coloproctology of Great Britain and Ireland (ACPGBI) guidelines on the role of faecal immunochemical testing (FIT) in the endoscopic investigation of iron deficiency anaemia (IDA) 2025
The rapidly emerging evidence base for the use of faecal immunochemical testing (FIT) in the investigation of possible colorectal malignancy has resulted in widespread use of FIT as a triage tool between primary and secondary care. This has caused some disruption to established investigation pathways for iron deficiency anaemia (IDA) and confusion regarding the role of FIT in planning any investigation, especially with regard to the upper gastrointestinal (UGI) tract. To provide some clarity, the British Society of Gastroenterology (BSG) commissioned a small group drawn from the guideline groups for both the BSG faecal immunochemical test (FIT)1 and iron deficiency anaemia (IDA)2 guidelines, the BSG endoscopy section and the Association of Coloproctology of Great Britain and Ireland (ACPGBI) to assess current evidence and produce guidelines.